Q BioMed Announces FDA Approval
Q BioMed Inc. (QBIO), announces FDA approval of its contract manufacturer IsoTherapeutics Group LLC. IsoTherapeutics is now cleared to manufacture the Company's FDA approved non-opioid cancer bone pain drug Strontium-89 Chloride USP.
View full press release